| |
|
|
|
Oramed Pharma
|
|
8.22 +0.11 (+1.36%) |
8/21/2017 4:00pm |
|
Open: |
8.08 |
Pre close: |
8.11 |
Target:
|
10.03
|
|
High: |
8.25 |
Low: |
8.08 |
Resistance:
|
8.59
9.17
|
|
Volume: |
20,951 |
Market Cap: |
109.49M |
Support:
|
7.64
6.36
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.14
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
8.07  |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
7.74 |
Stochastic Oscillator |
%K(14,3):
|
62.30 |
|
MA(250): |
7.04 |
%D(3): |
59.68 |
|
Average Volume(K) |
3-Month: |
2981
|
52-Week |
High:
|
9.17 |
|
10-Days: |
911 |
Low: |
5.70 |
|
RSI |
RSI(14):
|
55.50 |
Change(%): |
6.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.950 |
Return on Equity (ttm) |
-49.4 |
Shares Out. (M) |
13.32 |
|
EPS Est. Current Year |
-0.980 |
Return on Assets (ttm) |
-18.8 |
Shares Float (M) |
9.71 |
|
EPS Est. Next Year |
-1.270 |
PEG Ratio |
0.00 |
% Held by Insiders |
21.13 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
278.5 |
% Held by Institutions |
2.90 |
|
Forward EPS |
-1.270 |
Gross Profit (p.s.) |
0.011 |
Shares Short (K) |
185 |
|
Book Value (p.s.) |
1.490 |
EBITDA (p.s.) |
-0.860 |
P/E |
-8.65 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.52 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
3.02 |
P/S |
644061184.00 |
|
Operating Margin |
-522.91 |
Levered Free Cash Flow
(M) |
-2.45 |
P/CF |
36.26 |
|
|
|
|
|
|
|
